Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VALGANCICLOVIR HYDROCHLORIDE AMORPHOUS, with a corresponding US DMF Number 23044.
Remarkably, this DMF maintains an Active status since its submission on August 04, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 09, 2013, and payment made on December 21, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II